https://www.ndtvprofit.com/research-reports/aurobindo-pharma-q3-results-review-niche-products-led-earnings-growth-motilal-oswal?utm_source=telegram&utm_medium=referral&utm_campaign=socialshare
Product mix benefit and better operating leverage led improved margins.